New Portland Cement-based Materials for Endodontics Mixed with Articaine Solution: A Study of Cellular Response

Journal of Endodontics

Volumn 34, Issue 1, 2008, Pages 39-44

  Gandolfi, Maria Giovanna ^a   Perut, Francesca ^b   Ciapetti, Gabriela ^b   Mongiorgi, Romano ^a   Prati, Carlo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Laboratory for Pathophysiology of Orthopaedic Implants   (Italy)

Author keywords

Biocompatibility; calcium silicate; crystals; cytotoxicity; endodontic materials; fluoride; phyllosilicate; Portland cement

Indexed keywords

ARTICAINE; LOCAL ANESTHETIC AGENT; PORTLAND CEMENT; ROOT CANAL FILLING MATERIAL; TOOTH CEMENT; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; HUMAN; NONPARAMETRIC TEST; OSTEOBLAST; ULTRASTRUCTURE;

ANESTHETICS, LOCAL; CARTICAINE; CELL PROLIFERATION; CELL SURVIVAL; DENTAL CEMENTS; HUMANS; OSTEOBLASTS; ROOT CANAL FILLING MATERIALS; STATISTICS, NONPARAMETRIC;

EID: 37249006457     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joen.2007.09.001     Document Type: Article

References (38)

1. Camilleri J., and Pitt Ford T.R. Mineral trioxide aggregate: a review of the constituents and biological properties of the material. Int Endod J 39 (2006) 747-754
2. Koh E.T., McDonalg F., Pitt Ford T.R., and Torabinejad M. Cellular response to mineral trioxide aggregate. J Endod 24 (1998) 543-547
3. Saidon J., He J., Zhu Q., Safavi K., and Spangberg L.S.W. Cell and tissue reactions to mineral trioxide aggregate and Portland cement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 (2003) 483-489
4. Ribeiro D.A., Durante M.A.H., Matsumoto M.A., Marques M.E.A., and Salvadori T.M.F. Biocompatibility in vitro tests of mineral trioxide aggregate and regular and white Portland cements. J Endod 31 (2005) 605-607
5. Bonson S., Jeansonne B.G., and Lallier T.E. Root-end filling materials alter fibroblast differentiation. J Dent Res 83 (2004) 408-413
6. Al-Awadhi S., Spears R., Gutmann J.L., and Opperman L.A. Cultured primary osteoblast viability and apoptosis in the presence of root canal sealers. J Endod 30 (2004) 527-533
7. Torabinejad M., Watson T.F., and Pitt Ford T.R. Sealing ability of a mineral trioxide aggregate when used as a root-end filling material. J Endod 19 (1993) 591-595
8. Pelliccioni G.A., Vellani C.P., Gatto M.R.A., Gandolfi M.G., Marchetti C., and Prati C. Proroot mineral trioxide aggregate cement used as a retrograde filling without addition of water: an in vitro evaluation of its microleakage. J Endod 33 (2007) 1082-1085
9. Martin R.L., Monticelli F., Brackett W.W., et al. Sealing properties of mineral trioxide aggregate orthograde apical plugs and root filling in an in vitro apexification model. J Endod 33 (2007) 272-275
10. Gandolfi M.G., Prati C., Pagani S., Ciapetti G., and Mongiorgi R. Osteoblast-like cell response to new mineral endodontic cements. (abstract m 0796). J Dent Res (2007)
11. Gandolfi M.G., De Carlo B., Zanna S., Sauro S., Prati C., and Mongiorgi R. Chemical and physical characterization of a tetrasilicate-based mineral cement. It J Oper Dent 4 (2006) 80
12. Gandolfi M.G., Sauro S., Mannocci F., et al. New tetrasilicate cement as retrograde filling material: an in vitro study on fluid penetration. J Endod 33 (2007) 742-745
13. Abdullah D., Pitt Ford T.R., Papaioannou S., Nicholson J., and McDonald F. An evaluation of accelerated Portland cement as a restorative material. Biomaterials 23 (2002) 4001-4010
14. Kogan P., He J., Glickman G.N., and Watanabe I. The effect of various additives on setting properties of MTA. J Endod 32 (2006) 569-572
15. Al-Rabeah E., Perinpanayagam H., and MacFarland D. Human alveolar bone cells interact with ProRoot and Tooth-colored MTA. J Endod 32 (2006) 872-875
16. VanderWeele R.A., Schwartz S.A., and Beeson T.J. Effect of blood contamination on retention characteristics of MTA when mixed with different liquids. J Endod 32 (2006) 421-424
17. Bortoluzzi E.A., Broon N.J., Durante M.A.H., Oliveira Demarchi A.C.C., and Bramante C.M. The use of a setting accelerator and its effect on pH and calcium ion release of mineral trioxide aggregate and white Portland cement. J Endod 32 (2006) 1194-1197
18. Juenger M.C.G., Monteiro P.J.M., Gartner E.M., and Denbeaux G.P. A soft X-ray microscope investigation into the effects of calcium chloride on tricalcium silicate hydratation. Cem Concr Res 35 (2005) 19-25
19. Coomaraswamy K.S., Lumley P.J., and Hofman M.P. Effect of bismuth oxide radiopacifier content on the material properties of an endodontic Portland cement-based (MTA-like) system. J Endod 33 (2007) 295-298
20. Lau K.H.W., and Baylink D.J. Molecular mechanism of action of fluoride on bone cells. J Bone Miner Res 13 (1998) 1660-1667
21. Nakade O., Koyama H., Arai J., Ariji H., Takada J., and Kaku T. Stimulation by low concentrations of fluoride of the proliferation and alkaline phosphatase activity of human dental pulp cells in vitro. Arch Oral Biol 44 (1999) 89-92
22. Rodan S.B., Imai Y., Thiede M.A., et al. Characterization of a human osteosarcoma cell line SaOS-2 with osteoblastic properties. Cancer Res 47 (1987) 4961-4966
23. Murray E., Provvedini D., Curran D., Catherwood B., Sussman H., and Manolagas S. Characterization of a human osteoblastic osteosarcoma cell line (SaOS-2) with high bone alkaline phosphatase activity. J Bone Miner Res 2 (1987) 231-238
24. Ahmad M., McCarthy M., and Gronowics G. An in vitro model for mineralization of human osteoblast-like cells on implant materials. Biomaterials 20 (1999) 211-220
25. Camilleri J., Montesin F.E., Papaioannou S., McDonald F., and Pitt Ford T.R. Biocompatibility of two commercial forms of mineral trioxide aggregate. Int Endod J 37 (2004) 699-704
26. Anderson H.C., Hsu H.H.T., Raval P., et al. The mechanism of bone induction and bone healing by human osteosarcoma cell extracts. Clin Orthop 313 (1995) 129-134
27. Huang T.H., Ding S.J., Hsu T.C., and Kao C.T. Effects of mineral trioxide aggregate (MTA) extracts on mitogen-activated protein kinase activity in human osteosarcoma cell line (U2OS). Biomaterials 24 (2003) 3909-3913
28. Wang W.H., Lin F.H., Lee Y.L., and Lin C.P. Cytotoxicity of partial-stabilized cement. J Biomed Mater Res 81A (2007) 195-204
29. Nair P.N.R. On the cases of persistent apical periodontitis: a review. Int Endod J 39 (2006) 249-281
30. Camilleri J., Montesin F.E., Brady K., Sweeney R., Curtis R., and Pitt Ford T.R. The constitution of mineral trioxide aggregate. Dent Mater 21 (2005) 297-303
31. Dammaschke T., Gerth H.U.V., Zuchner H., and Schafer E. Chemical and physical surface and bulk material characterization of white ProRoot MTA and two Portland cements. J Endod 21 (2005) 731-738
32. Danesh G., Dammaschke T., Gerth H.U.V., Zandbiglari T., and Schafer E. A comparative study of selected properties of ProRoot mineral trioxide aggregate and two Portland cements. Int Endod J 39 (2006) 213-219
33. Song J.S., Mante F.K., Romanow W.J., and Kim S. Chemical analysis of powder and set forms of Portland cement, gray ProRoot MTA; white ProRoot MTA, and gray MTA-Angelus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 (2006) 809-815
34. Camilleri J. Hydratation mechanisms of mineral trioxide aggregate. Int Endod J 40 (2007) 462-467
35. Sarkar N.K., Caceido R., Ritwik P., Moiseyeva R., and Kawashima I. Physicochemical basis of the biologic properties of mineral trioxide aggregate. J Endod 31 (2005) 97-100
36. Smith J.B., Loushine R.J., Weller R.N., et al. Metrologic evaluation of the surface of white MTA after the use of two endodontic irrigants. J Endod 33 (2007) 463-467
37. Huang T.H., Ding S.J., Hsu T.C., and Kao C.T. Effects of mineral trioxide aggregate (MTA) extracts on mitogen-activated proteinkinase activity in human osteosarcoma cell line (U2OS). Biomaterials 24 (2003) 3909-3913
38. Nakayama A., Ogiso B., Tanabe N., Takeichi O., Matsuzaka K., and Inoue T. Behaviour of bone marrow osteoblast-like cells on mineral trioxide aggregate: morphology and expression of type I collagen and bone-related protein mRNAs. Int Endod J 38 (2005) 203-210